` OSE (OSE Immunotherapeutics SA) vs DAX Index Comparison - Alpha Spread

OSE
vs
DAX Index

Over the past 12 months, OSE has underperformed DAX Index, delivering a return of -25% compared to the DAX Index's 29% growth.

Stocks Performance
OSE vs DAX Index

Loading
OSE
DAX Index
Add Stock
www.alphaspread.com

Performance Gap
OSE vs DAX Index

Loading
OSE
DAX Index
Difference
www.alphaspread.com

Performance By Year
OSE vs DAX Index

Loading
OSE
DAX Index
Add Stock

Competitors Performance
OSE Immunotherapeutics SA vs Peers

DAX Index
OSE
ABBV
AMGN
GILD
VRTX
Add Stock

OSE Immunotherapeutics SA
Glance View

Market Cap
130.6m EUR
Industry
Biotechnology

OSE Immunotherapeutics SA develops immunotherapy products for cancer and auto-immune disease. The company is headquartered in Nantes, Pays De La Loire and currently employs 61 full-time employees. The company went IPO on 2015-03-30. The company develops immunotherapies, directly or through partnerships, for the activation and regulation of the immune system in immuno-oncology and in autoimmune diseases. The firm's research and development in immunology is based on 3 platforms, such as T cell-based vaccines, Immuno-Oncology (myeloid targets) and Auto-Immunity & Inflammation. The company provides technological and scientific platforms: neoepitopes, agonist or antagonist monoclonal antibodies, ideally positioned to fight cancer and autoimmune diseases.

OSE Intrinsic Value
4.696 EUR
Overvaluation 21%
Intrinsic Value
Price
Back to Top